Document Classification

Section Type: RESULTS

Text: The primary outcome, maximal brain infarct size at days 3 and 30 measured by perfusion computed tomography, was not significantly altered by random assignment to irbesartan (1088 (IQR 216, 2594) mm at day 3, compared with 398 (144, 2053) mm among the placebo group, P = 0. 79 controlling for baseline values ; and 822 (159, 1717) mm at day 30, cf 280 (76, 1330) mm ; P = 0. 63) ; or atorvastatin (454 (107, 1765) mm cf 825 (265, 2509) mm at day 3 ; P = 0. 33 ; and 462 (43, 1399) mm cf 280 (128, 1559) mm at day 30, P = 0. 79).